The Ability of Mouse Monoclonal Antibodies to Direct the Cytotoxic Function of Cytokine-Activated Human Eosinophils

This publication has 24 references indexed in Scilit:

• Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.
  Journal of Clinical Investigation, 1988
• Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1987
• Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer
  New England Journal of Medicine, 1987
• Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae.
  Proceedings of the National Academy of Sciences, 1986
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985
• Identification by monoclonal antibody of a major (28 kDa) surface membrane antigen of Schistosoma mansoni
  Molecular and Biochemical Parasitology, 1985
• Schistosoma mansoni. Anti-egg monoclonal antibodies protect against cercarial challenge in vivo.
  The Journal of Experimental Medicine, 1984
• Enhancement of human blood eosinophil cytotoxicity by semi-purified eosinophil colony-stimulating factor(s).
  The Journal of Experimental Medicine, 1982
• Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose
  Immunochemistry, 1978
• Schistosoma mansoni: Defined system for stepwise transformation of cercaria to schistosomule in vitro
  Experimental Parasitology, 1974